Philip Chase - CEO @ Adimab - Crunchbase Person Profile

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

113,169

Primary Job Title CEO
Primary Organization
Adimab

Location Needham, Massachusetts, United States
Regions Greater Boston Area, East Coast, New England
Gender Male

LinkedIn View on LinkedIn

Philip Chase is the current CEO of Adimab. He previously worked at Alnylam Pharmaceuticals as a General Counsel. Philip Chase attended Columbia Law School.

Jobs

Number of Current Jobs

Number of Past Jobs

Philip Chase

is the

CEO

Adimab

. Additionally,

Philip Chase

has had

past jobs including

General Counsel

Adimab

Adimab CEOMay 2022

Organization Name	Title At Company	Start Date	End Date
Adimab	General Counsel	Nov 2011	2022
Alnylam Pharmaceuticals	General Counsel	2007	2011
Epix Pharmaceuticals	General Counsel	2005	2006
RenaMed Biologics	General Counsel	2006	2006
Transkaryotic Therapies, Inc	Associate General Counsel	2000	2005
TKT	Associate General Counsel	2000	2005
Shearman & Sterling	Associate	1999	2000
Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates	Associate	1995	1999

Board and Advisor Roles

Number of Current Board & Advisor Roles

Philip Chase

is the

Board Member

Invivyd

Invivyd Board MemberJul 2020

Related Hubs

Hub Name	CB Rank (Hub)
Therapeutics Companies With More Than 50 Employees	13,520
Therapeutics Companies With Less Than $500M in Revenue (Top 10K)	8,587
Therapeutics Companies With Less Than $1B in Revenue (Top 10K)	8,502
Collaboration Companies With Fewer Than 1000 Employees	12,110
Therapeutics Companies With More Than 100 Employees	14,625
New England Companies With Less Than $50M in Revenue (Top 10K)	2,345
Dartmouth College Alumni Founded Companies	94,189
Biotechnology Companies With More Than 100 Employees	3,087
Investors Active in Massachusetts	1,726
OrbiMed Portfolio Companies	43,079